(Q47718393)

English

Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Duchatelle V

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Marcellin P

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Giostra E

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Bregeaud L

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Pouteau M

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Boyer N

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Auperin A

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Guerret S

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Erlinger S

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Henin D

10

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Degott C

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

29

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

20-28

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective inhibition of human diploid fibroblast collagen synthesis by interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic fibrosis--new therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of fibrosis in needle liver biopsies: evaluation of a colorimetric method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980174-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(98)80174-8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9696488

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47718393&oldid=2166947561"